Triall TRL Price

What is Triall (TRL)?

Triall (TRL): Revolutionizing Clinical Trials Through Blockchain Innovation

Triall (TRL) is at the forefront of transforming the landscape of clinical trials with its comprehensive suite of eClinical solutions, leveraging blockchain, Artificial Intelligence, and related technologies. Founded in 2018 by clinical operations experts Raymond van der Waal, Mark van der Waal, and Hadil Es-Sbai, the company addresses the challenges faced by clinical researchers and trial participants in the digital age.

End-to-End Ecosystem

Triall's platform provides end-to-end solutions, offering web-based, mobile, and wearable integration capabilities for remote data collection. The ecosystem includes core solutions such as Verial eTMF, a clinical document management application with blockchain proofs of data integrity, and Atena PRM, a vendor selection and management platform with blockchain proofs of fair tender processes.

TRL Token

At the heart of the Triall ecosystem is the TRL token, the main utility token that grants users access to applications and APIs. Beyond transactional use, TRL plays a pivotal role in engaging stakeholders, allowing them to shape the direction of the ecosystem for long-term sustainability. The launch of an exclusive TRL Staking Program, with APRs of up to 250%, demonstrates Triall's commitment to rewarding early adopters and supporters.

Blockchain for Trust and Efficiency

Clinical trials often involve vast amounts of electronic systems and data, leading to a lack of oversight and concerns about data integrity. Triall utilizes world-class blockchain technology to secure clinical trial data, enhancing efficiency, trust, and regulatory compliance for all involved parties. This innovation promotes traceability, auditability, and secure transfer of data between organizations and systems.

Unique Ecosystem Approach

What sets Triall apart is its 'ecosystem approach' to clinical trials. By enabling secure and compliant integrations between isolated clinical trial software, Triall aims to turn competitors into cooperators, fostering faster and more efficient trials. The project leverages emerging open blockchain standards like Decentralized Identifiers (DIDs) and Verifiable Credentials (VCs) to establish a decentralized identity and access management infrastructure, ensuring secure connections between systems and users.

Mission and Collaboration

Triall's mission is rooted in advancing clinical trials in the digital era, promoting security, quality, efficiency, and decentralized collaboration among clinicians and patients. Since 2018, the company has collaborated with industry and academia to design, develop, and demonstrate key enabling technologies. Triall believes in innovating atop existing and industry-validated eClinical technology platforms, gradually introducing features for improved cross-system collaboration.

In conclusion, Triall's pioneering efforts in the clinical trials industry showcase its commitment to addressing industry-wide challenges through blockchain innovation. By promoting traceability, interoperability, and collaboration, Triall aims to accelerate the development of safe and affordable new vaccines and therapeutics, ushering in a new era for clinical trials.

What is unique about Triall (TRL)?

Triall stands out in the clinical trials industry by employing blockchain technology to enhance traceability, auditability, and secure data transfer between systems, fostering collaboration among competitors for more efficient trials.

Who are the founders of Triall (TRL)?

Triall was founded in 2018 by a team of clinical operations experts, including Raymond van der Waal, Mark van der Waal, and Hadil Es-Sbai. Their extensive experience in managing over 100 clinical trials and co-founding multiple ventures has positioned Triall as a leader in the field.

Where can I buy Triall (TRL)?

You can buy Triall (TRL) on PancakeSwap (v2) cryptocurrency exchanges.